Cargando…

Novel Ubiquitin Specific Protease-13 Inhibitors Alleviate Neurodegenerative Pathology

Ubiquitin Specific Protease-13 (USP13) promotes protein de-ubiquitination and is poorly understood in neurodegeneration. USP13 is upregulated in Alzheimer’s disease (AD) and Parkinson’s disease (PD), and USP13 knockdown via shRNA reduces neurotoxic proteins and increases proteasome activity in model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaoguang, Balaraman, Kaluvu, Lynch, Ciarán C., Hebron, Michaeline, Wolf, Christian, Moussa, Charbel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467576/ https://www.ncbi.nlm.nih.gov/pubmed/34564439 http://dx.doi.org/10.3390/metabo11090622

Ejemplares similares

Inhibition of Ubiquitin-Specific Protease-13 Improves Behavioral Performance in Alpha-Synuclein Expressing Mice
por: Liu, Xiaoguang, et al.
Publicado: (2022)

Ubiquitination Increases Parkin Activity to Promote Autophagic α-Synuclein Clearance
por: Lonskaya, Irina, et al.
Publicado: (2013)

Two sides of the same coin: tyrosine kinase inhibition in cancer and neurodegeneration
por: Hebron, Michaeline, et al.
Publicado: (2015)

Fractalkine Mediates Communication between Pathogenic Proteins and Microglia: Implications of Anti-Inflammatory Treatments in Different Stages of Neurodegenerative Diseases
por: Desforges, Nicole M., et al.
Publicado: (2012)

4564 Nilotinib alters microRNAs that regulate specific autophagy and ubiquitination genes in the cerebrospinal fluid of Parkinson’s patients
por: Fowler, Alan, et al.
Publicado: (2020)

Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models
por: Lonskaya, Irina, et al.
Publicado: (2014)

Chemodivergent Csp(3)─F bond functionalization and cross-electrophile alkyl-alkyl coupling with alkyl fluorides
por: Balaraman, Kaluvu, et al.
Publicado: (2022)

Inhibition of discoidin domain receptor (DDR)-1 with nilotinib alters CSF miRNAs and is associated with reduced inflammation and vascular fibrosis in Alzheimer’s disease
por: Stevenson, Max, et al.
Publicado: (2023)

Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance
por: Lonskaya, Irina, et al.
Publicado: (2013)

Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration
por: Fowler, Alan J., et al.
Publicado: (2019)

Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy
por: Hebron, Michaeline L., et al.
Publicado: (2014)

Click chemistry enables quantitative chiroptical sensing of chiral compounds in protic media and complex mixtures
por: Thanzeel, F. Yushra, et al.
Publicado: (2018)

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
por: Moussa, Charbel, et al.
Publicado: (2017)

Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment
por: Huang, Mei-Ling, et al.
Publicado: (2022)

Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease
por: Pagan, Fernando L., et al.
Publicado: (2020)

Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies
por: Pagan, Fernando L., et al.
Publicado: (2022)

Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington’s Disease Patients
por: Anderson, Karen E., et al.
Publicado: (2022)

The Relationship between Parkin and Protein Aggregation in Neurodegenerative Diseases
por: Khandelwal, Preeti J., et al.
Publicado: (2010)

Identification of candidate substrates of ubiquitin-specific protease 13 using 2D-DIGE
por: Wang, Jianmin, et al.
Publicado: (2017)

CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease
por: Fowler, Alan J., et al.
Publicado: (2021)

Substrate specificity of the ubiquitin and Ubl proteases
por: Ronau, Judith A, et al.
Publicado: (2016)

Ubiquitin pathways in neurodegenerative disease
por: Atkin, Graham, et al.
Publicado: (2014)

Ubiquitin, Autophagy and Neurodegenerative Diseases
por: Watanabe, Yoshihisa, et al.
Publicado: (2020)

Ubiquitin-specific protease 4 is inhibited by its ubiquitin-like domain
por: Luna-Vargas, Mark P A, et al.
Publicado: (2011)

The Molecular Basis for Ubiquitin and Ubiquitin-like Specificities in Bacterial Effector Proteases
por: Pruneda, Jonathan N., et al.
Publicado: (2016)

Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders
por: Kitamura, Hiroshi
Publicado: (2023)

Ubiquitin-Proteasome System in Neurodegenerative Disorders
por: Rao, Geeta, et al.
Publicado: (2015)

Ubiquitin and Ubiquitin-like Proteins in Cancer, Neurodegenerative Disorders, and Heart Diseases
por: Hwang, Jin-Taek, et al.
Publicado: (2022)

Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes
por: Cruz, Lucas, et al.
Publicado: (2021)

Emerging Roles of Ubiquitin-Specific Protease 25 in Diseases
por: Zhu, Wenjing, et al.
Publicado: (2021)

Phosphorylation and activation of ubiquitin-specific protease-14 by Akt regulates the ubiquitin-proteasome system
por: Xu, Daichao, et al.
Publicado: (2015)

Ubiquitin‐specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1‐dependent pathway
por: Miao, Rujia, et al.
Publicado: (2020)

Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases
por: Zheng, Qiuyang, et al.
Publicado: (2016)

Structural basis for the SUMO protease activity of the atypical ubiquitin-specific protease USPL1
por: Li, Ying, et al.
Publicado: (2022)

Understanding and predicting the potency of ROS-based enzyme inhibitors, exemplified by naphthoquinones and ubiquitin specific protease-2
por: Gopinath, Pushparathinam, et al.
Publicado: (2016)

Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21
por: Göricke, Fabian, et al.
Publicado: (2023)

Extracellular Vesicle Treatment Alleviates Neurodevelopmental and Neurodegenerative Pathology in Cortical Spheroid Model of Down Syndrome
por: Campbell, Natalie Baker, et al.
Publicado: (2023)

Ubiquitin-specific proteases UBP12 and UBP13 promote shade avoidance response by enhancing PIF7 stability
por: Zhou, Yu, et al.
Publicado: (2021)

The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
por: Loiseau, Philippe M., et al.
Publicado: (2022)

The ubiquitin specific protease USP34 promotes ubiquitin signaling at DNA double-strand breaks
por: Sy, Shirley M. H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hjq0uofn4ar2ctqk07mavu8lhe